AIM
AIM
AMEX · Biotechnology

Aim Immunotech Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$0.28
+0.01 (+5.02%)
As of Aug 8, 2:36 AM ET ·
Analyst Consensus
Strong Buy
6
Analysts
Moderate
Coverage
Buy 5 83%
Hold 1 17%
Sell 0 0%
Price Target
Analyst Price Target +7,670.7% upside
Low Target $15.13
Average Target $22.10
High Target $31.02
Current Price $0.28
Current
$0.28
Target
$22.10
$15.13 $22.10 avg $31.02
Scenario Analysis
Bear Case
$15.13
5,220.0%
Low target
Base Case
$22.10
+7,670.7%
Avg target
Bull Case
$31.02
+10,807.2%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$2.89
-90.2% from high
52-Week Low
$0.21
+35.4% from low
Target vs 52W High
$22.10
+664.7% vs high
Next Earnings Report
Aug 12, 2026
2d
until earnings
EPS Est: $-0.17
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 38 82% $257.58 +4.7%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 37 81% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -90.2%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -44.4%
BIIB
Biogen Inc
 Buy 43 67% $91.45 -56.0%